5 active trials 2 recruiting 3 Phase 3 2 disease areas
| Phase 2 | 1 | |
| Phase 3 | 3 | |
| Phase 4 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT07695701 | Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis | Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) | Recruiting | 2026-07-29 |
| Phase 3 | ||||
| NCT06563895 | Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in… | Amyloidosis | Recruiting | 2026-08-04 |
| NCT07116473 | To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With… | Amyloidosis in Transthyretin (TTR) | Not Yet Recruiting | 2026-08-11 |
| NCT04988386 | Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants | Amyloid Cardiomyopathy, Transthyretin-Related | Active, Not Recruiting | 2025-10-14 |
| Phase 2 | ||||
| NCT03536767 | Open-Label Study of AG10 in Patients with Cardiomyopathy | Amyloid Cardiomyopathy | Active, Not Recruiting | 2025-03-13 |
Amyloidosis (5) · Heart Disease (2)